Cargando…
Highly Frequent and Enhanced Injection Site Reaction Induced by Peripheral Venous Injection of Fosaprepitant in Anthracycline-Treated Patients
Background: Fosaprepitant-associated injection site reaction (ISR) has been reported in patients treated with cisplatin, an irritant drug. We conducted this retrospective study to clarify the incidence and symptoms of fosaprepitant-associated ISR in patients treated with anthracycline. Patients and...
Autores principales: | Sato, Yumiko, Kondo, Masahiro, Inagaki, Atsushi, Komatsu, Hirokazu, Okada, Chika, Naruse, Kumi, Sahashi, Tomoyo, Kuroda, Junko, Ogura, Hiroka, Uegaki, Shiori, Yoshida, Tatsuya, Mori, Yoshinori, Sawada, Hiroo, Watanabe, Shoichi, Sugiura, Hiroshi, Endo, Yumi, Yoshimoto, Nobuyasu, Toyama, Tatsuya, Iida, Shinsuke, Yamada, Koichi, Kimura, Kazunori, Wakita, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007527/ https://www.ncbi.nlm.nih.gov/pubmed/24799957 http://dx.doi.org/10.7150/jca.7706 |
Ejemplares similares
-
Myoepithelial Carcinoma of the Breast Treated with Surgery and Chemotherapy
por: Endo, Yumi, et al.
Publicado: (2013) -
Collaborative care intervention for the perceived care needs of women with breast cancer undergoing adjuvant therapy after surgery: a feasibility study
por: Momino, Kanae, et al.
Publicado: (2017) -
Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant
por: Olver, Ian N
Publicado: (2008) -
Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting
por: Langford, Patrick, et al.
Publicado: (2010) -
Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectives
por: Candelario, Nellowe, et al.
Publicado: (2016)